Genmab — Juli 2018
-
Interview – Why Immatics could soon become the next listed cell therapy player - by EPVantage - http://www.epvantage.com/Universal/View.aspx?type=Story&id=802624&isEPVantage=yes
-
-
Mornings - er i klar til usd 530m senere i dag?
-
Kommer tallene lige efter lukketid?
-
Kl. 12.40 i dag
-
Morning J.Varnæs, vi er mere end klar
-
@stockbull, det der med at konsensus, det er vidst kun Børsen, der er kommet frem til det. Jeg er mere end svært ved at se, hvordan man er kommet frem til det
-
465mio
-
Kan ikke se børsen link ... afspiller ikke.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind